Upregulation of SIRT1 has been reported in various human malignancies including prostate cancer, breast cancer, lung cancer, lymphoma, leukemia, soft tissue sarcomas, colon cancer, and gastric cancer [11, 14–19]. Here, SIRT1 is linked to prostate cancer.